Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Emergent Biosolutions
(NY:
EBS
)
11.87
-2.90 (-19.63%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Emergent Biosolutions
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 30, 2023
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...
Via
Benzinga
Why Emergent BioSolutions Stock Is Soaring Today
March 30, 2023
Emergent received a key approval from the FDA, but just how good is this news?
Via
The Motley Fool
Sprinklr, EVgo, Emergent BioSolutions And Other Big Stocks Moving Higher On Thursday
March 30, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
FDA Approves First OTC Naloxone Nasal Spray For Opioid Overdose
March 29, 2023
Via
Benzinga
Why Emergent BioSolutions Stock Is Sinking Today
March 17, 2023
Investors reacted negatively to an analyst's downgrade of the healthcare stock.
Via
The Motley Fool
Emergent Biosciences (EBS) Stock Pops as FDA Approves Over-the-Counter Narcan
March 29, 2023
EBS stock is on the move as Emergent Biosciences expects its opioid emergency drug to be available soon without a prescription.
Via
InvestorPlace
FDA Approves Over The Counter Sale Of Opioid Reversal Drug Narcan
March 29, 2023
Narcan, the prescription nasal spray that reverses opioid overdoses can now be sold over the counter (OTC), said the FDA on Wednesday, reported the NY Times, thereby authorizing a move that has...
Via
Benzinga
Why Emergent Biosolutions Stock Is Surging Today
March 29, 2023
Emergent Biosolutions Inc (NYSE: EBS) shares are trading higher Wednesday following reports the U.S. Food and Drug Administration approved the company's Naloxone nasal spray for over-the-counter use.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 29, 2023
Via
Benzinga
Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket
March 29, 2023
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong revenue and margin growth for the year ended 2022.
Via
Benzinga
Earnings Outlook For Emergent BioSolutions
February 24, 2023
Via
Benzinga
Cal-Maine Foods, Lululemon Athletica And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
March 29, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 17, 2023
Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp.
Via
Benzinga
First Republic Bank, Blend Labs, Purple Innovation And Other Big Stocks Moving Lower On Friday
March 17, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
March 17, 2023
Via
Benzinga
Why Cassava Sciences Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
March 09, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 09, 2023
It's time for another breakdown of the biggest pre-market stock movers traders will want to know about on Thursday morning!
Via
InvestorPlace
Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional'
March 01, 2023
Novavax Inc (NASDAQ: NVAX) shares are crashing Wednesday after the company warned that substantial doubt exists regarding its ability to continue. Jim Cramer isn't surprised.
Via
Benzinga
Why Emergent BioSolutions Stock Tumbled by Almost 12% Today
February 28, 2023
It's not a good day for investors when their company reports a shocking plunge into the red.
Via
The Motley Fool
Emergent BioSolutions (EBS) Q4 2022 Earnings Call Transcript
February 27, 2023
EBS earnings call for the period ending December 31, 2022.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 16, 2023
Via
Benzinga
Why Axcella Health Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket
February 16, 2023
Gainers Axcella Health Inc. (NASDAQ: AXLA) shares rose 54.1% to $0.9290 in pre-market trading after the company announced FDA clearance of its IND application to initiate a phase 2b/3 trial in the U.S....
Via
Benzinga
Earnings Scheduled For February 27, 2023
February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 16, 2023
It's time to start the day with an overview of the biggest pre-market stock movers worth keeping an eye on Thursday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 15, 2023
Via
Benzinga
Monkeypox Vaccine Maker Bavarian Nordic Bets $380M On Emergent Bio's Travel Vaccines
February 15, 2023
Via
Benzinga
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
January 31, 2023
The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new...
Via
Benzinga
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
January 13, 2023
Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
November 18, 2022
On Friday, 64 companies achieved new lows for the year.
Via
Benzinga
EXCLUSIVE: SAB Biotherapeutics Posts Wider Quarterly Loss, Cash Runway Expected Into Mid-2023
November 15, 2022
SAB Biotherapeutics' (NASDAQ: SABS) Q3 net loss reached $(7.1) million, equivalent to an EPS loss of $(0.16), as compared to a net loss of $(4.1) million a year ago. Cash and cash equivalents were $8.3...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.